PRODUCTS
|
|
Velos eResearch is the highly-regarded clinical research information system chosen by 20 medical institutions with top 25 ratings in U.S. News and World Report.
Velos eResearch supports patient recruitment, patient scheduling, IRB and study monitoring, project planning, study design, protocol compliance, budget, invoicing, and milestone management; data safety monitoring, adverse event reporting, system integration and study execution.
For investigators, opportunities abound for better use of information systems and clinical databases in medical research. This sounds obvious but such systems are not generally in production today. At least 95% of study administration is done on paper, in spreadsheets, and on various, sundry databases. A structured approach --- an integrated, network-based system --- gives investigators, study coordinators and central managers within major research centers unprecedented research information capabilities. Velos is that solution.
For sponsors, Velos eResearch is solving "the last mile" problem. Velos provides end-to-end electronic clinical trial data collection, where study data comes directly from source systems (e.g. labs, adverse events and medical records) at the sites, to the lead investigator and monitors, and on to the CRO and/or sponsor. Such a system infrastructure is a major leap forward in clinical trial automation for both sponsors and investigators. Velos enables "Direct Data Capture" as compared to "Electronic Data Capture".
Unlike the vast majority of systems alternatives, Velos was designed from the ground up to support both study administration and clinical data management in a single, integrated environment. This integral design is central to Velos' noted ability to easily and elegant solve customers' research, information and coordination challenges. Key features in the two areas are:
STUDY ADMINISTRATION
- Protocol management
- Patient scheduling
- Regulatory reporting
- Adverse event management and reporting
- Budgeting, milestones, invoice, and payment/receipts processing
- Management of research organizations, personnel, and collaborators
CLINICAL DATA MANAGEMENT
- Patient profiling
- Longitudinal, patient-level information collection and analysis
- Study-specific data collection and analysis
- Workflow configuration
- Integration with internal and third party information systems
Notable advantages of Velos eResearch are:
- Access to what some believe is the most advanced, carefully considered clinical research information system that is commercially available.
- HL7 compliance. Dozens of working lab, medical record, and device interfaces are already in production.
- Velos was designed from the ground up to provide off-the-shelf support for all of study administration, clinical data management, adverse event reporting, and integration with internal and third party cancer center systems through one integrally-designed system.
- The ability to add, modify, and apply study- and customer-specific data dictionaries with minimal technical involvement.
- Compliance with industry standards (such as 21 CFR Part 11) and a commitment to supporting standards that foster higher collaboration. Velos is also centrally involved with U.S. government initiatives intended to foster greater collaboration among researchers.
- Patient-level and study-level system architecture. Most research systems were primarily designed for research sponsors and focus on the needs of single studies. The Velos eResearch system architecture is unique and considers both patient- and study-level views --- and also integrates the two.
- Advanced technology and security features to support multi-institutional, cooperative trials, community-based research and patient self-reporting ---- in a single and federated database environment.
- Through all these capabilities, Velos is helping to transform the information model in clinical research from its current, largely disintegrated state to one where investigators and sponsors can work hand and glove. In doing so, Velos believes it can help its customers, and the research community in general, unleash tremendous improvements in research productivity, collaboration, and, ultimately, patient care.
|
|
